2018 International Congress » Parkinson's Disease: Neuroimaging And Neurophysiology

Date: Monday, October 8, 2018

Time: 1:15pm-2:45pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:15pm-2:45pm: A comprehensive digital biomarker active testing and passive monitoring suite for the remote and frequent assessment of motor symptom progression in Parkinson’s disease

K. Taylor, R. Postuma, F. Boess, F. Lipsmeier, T. Kilchenmann, L. Verselis, J. Soto, M. Koller, C. Gossens, A. Post, J. Sevigny, M. Lindemann (Basel, Switzerland)

1:15pm-2:45pm: A cortical neural signature of motor interruption in patients with Parkinson’s disease and freezing of gait

J. Baarbé, M. Brown, U. Saha, K. Lizarraga, A. Weissbach, N. Drummond, C. Rinchon, P. Kapoor, J. Saravanamuttu, R. Chen (Toronto, ON, Canada)

1:15pm-2:45pm: A Florbetapir [F18] amyloid PET Imaging study in Parkinson’s disease Dementia (PDD): The influence of amyloid deposition on cognitive status and course of disease progression

G. Palermo, G. Aghakhanyan, L. Tommasini, D. Frosini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

1:15pm-2:45pm: A longitudinal PET study to assess progression of laterality in Parkinson’s disease

AA. Roussakis, N. Lao-Kaim, A. Martin-Bastida, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Abnormal Functional Connectivity in Cerebellar Locomotor Region is associated with the severity of freezing of gait in patients with Parkinson’s disease

K. Bearti, A. Suppa, S. Pietracupa, N. Upadhyay, C. Giannì, G. Leodori, F. Di Biasio, N. Modugno, N. Petsas, G. Grillea, A. Zampogna, A. Berardelli, P. Pantano (Rome, Italy)

1:15pm-2:45pm: Abnormal NMDA-related Electrophysiology in Parkinson Disease Dementia

J.C. Chen, H.M. Heng, C.H. Tsai (Taichung, Taiwan)

1:15pm-2:45pm: Absence of the nigrosome-1 area in 3 tesla resonance and its relation with hyperechogenicity of the substantia nigra in patients with Parkinson’s disease

J.S. Bestoso, M. Pérez Akly, L. Ciancaglini, C. Stefani C, J. Norscini, J. Funes, C. Besada, D. Bauso (Buenos Aires, Argentina)

1:15pm-2:45pm: Alteration to Basal Ganglia Morphology in Freezing of Gait in Parkinson’s Disease

N. D'Cruz, G. Vervoort, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

1:15pm-2:45pm: Alterations of cortical metabotropic glutamate receptor-mediated signaling in patients with Parkinson’s disease

JY. Lee, YK. Kim, SA. Shin, SH. Seo, JS. Lee, YS. Lee, JM. Jeong, B. Jeon (Seoul, Republic of Korea)

1:15pm-2:45pm: Altered connectivity in ventral and dorsal attentional networks in patients with Parkinson’s disease: Association with freezing of gait

I. Maidan, Y. Jacob, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

1:15pm-2:45pm: Altered putamen and cerebellum connectivity between different subtypes of Parkinson’s disease

B. Shen, L. Zhang (Nanjing, China)

1:15pm-2:45pm: Amyloid PET and cognition in Parkinson’s disease

T. Melzer, M. Stark, D. Myall, R. Keenan, L. Livingston, M. Almuqbel, M. MacAskill, T. Pitcher, K. Horne, S. Grenfell, M. Pascoe, B. Young, J. Wang, S. Marsh, D. Miller, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

1:15pm-2:45pm: Anti-glutamatergic effect of safinamide in Parkinson’s Disease: A TMS study

A. Guerra, A. Suppa, V. D'Onofrio, F. Di Stasio, F. Asci, G. Fabbrini, A. Berardelli (Rome, Italy)

1:15pm-2:45pm: Assessing working memory dysfunction with letter n-back functional MRI task in early-stage Parkinson’s disease

A. Martin-Bastida, N. Lao-Kaim, S. Pietracupa, M. Wall, A. Roussakis, Y. Xing, S. Schwarz, D. Auer, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Association between MAPT haplotype and hippocampal repetition suppression in Parkinson’s disease

E. Yoon, T. Alrazi, M. Ramezani, I. Kathol, J. Sarna, T. Hammer, L. Derwent, J. Cheetham, Z. Gan-Or, G. Rouleau, O. Monchi (Calgary, AB, Canada)

1:15pm-2:45pm: Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson Disease

H. Sanjari Moghaddam, F. Ghazi Sherbaf, M H. Aarabi, M. Mojtahed Zadeh (Tehran, Islamic Republic of Iran)

1:15pm-2:45pm: Association of Olfaction dysfunction with Brain Microstructure in Prodromal Parkinson disease

H. Sanjari Moghaddam, M.H. Aarabi, Z. Valitabar (Tehran, Islamic Republic of Iran)

1:15pm-2:45pm: Automated Differential Diagnosis of Parkinsonian Syndromes Using FDG-PET Metabolic Brain Network Analysis

T. Rus, P. Tomše, L. Jensterle, M. Grmek, Z. Pirtošek, D. Eidelberg, C. Tang, M. Trošt (Ljubljana, Slovenia)

1:15pm-2:45pm: Behavior and PET Imaging Study in Parkinsonian Rat Models Induced by Injection of 6-OHDA in Medial Forebrain Bundle

W. Xian, Q. Guo, L. Jiang, Z. Pei, L. Chen (Guangzhou, China)

1:15pm-2:45pm: Beta burst coupling across the motor circuit in patients with Parkinson’s disease

G. Tinkhauser, F. Torrecillos, Y. Duclos, H. Tan, A. Pogosyan, P. Fischer, R. Carron, M. Welter, C. Karachi, W. Vandenberghe, B. Nuttin, T. Witjas, J. Régis, J. Azulay, A. Eusebio, P. Brown (Oxford, United Kingdom)

1:15pm-2:45pm: Blink Recovery Pattern and Somatosensory Evoked Blink Reflex in patients with Parkinsonism syndromes

S. Tandra, R.M. Mridula, R. Borgohain (Hyderabad, India)

1:15pm-2:45pm: Brain network activation (BNA): A new biomarker for Parkinson’s disease?

S. Hassin-Baer, Z. Pereman, R. Yahav, S. Israeli-Korn, G. Yahalom, S. Benizri, R. Shani-Hershkovich, G. Issachar, A. Geva, O. Cohen (Ramat Gan, Israel)

1:15pm-2:45pm: Brain Network Connectivity Measured by Diffusion Tensor Imaging Predicts Prognosis in Parkinson’s Disease

S.M. Fereshtehnejad, N. Abbasi, Y. Zeighami, K. Larcher, R. Postuma, A. Dagher (Montreal, QC, Canada)

1:15pm-2:45pm: Brain responses evoked by thalamic and subthalamic deep brain stimulation

J. Hirschmann, C. Hartmann, J. Vesper, L. Wojtecki, M. Butz, A. Schnitzler (Düsseldorf, Germany)

1:15pm-2:45pm: Bupropion causing misdiagnosis in brain dopamine transporter imaging for parkinsonism

E. Honkanen, N. Kemppainen, T. Noponen, M. Seppänen, J. Joutsa, V. Kaasinen (Turku, Finland)

1:15pm-2:45pm: Can Preoperative Dopamine Transporter Imaging Predict the Long-Term Outcome of Deep Brain Stimulation in Patients with Parkinson’s Disease?

B. Thomsen, S. Jensen, A. Clausen, M. Karlsborg, E. Brødsgaard, L. Friberg, M. Lonsdale, A. Løkkegaard (Copenhagen, Denmark)

1:15pm-2:45pm: Cardiac sympathetic denervation can predict the wearing-off phenomenon in patients with Parkinson’s disease

S. Yoo, JS. Kim, JE. Lee, KS. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Cerebellar atrophy in different motor and non-motor subtypes of Parkinson’s disease

XX. Ma, CM. Li, W. Su, HB. Chen (Beijing, China)

1:15pm-2:45pm: Cerebrospinal fluid protein biomarkers in PD patients after DBS-STN surgery: A retrospective analysis of patients that underwent surgery between 1993 and 2001

R. Constantinescu, K. Blennow, L. Rosengren, B. Eriksson, T. Gudmundsdottir, Y. Jansson, A. Renck, F. Bergquist (Gothenburg, Sweden)

1:15pm-2:45pm: Changes in cortical thickness in patients with early Parkinson’s disease at different Hoehn and Yahr stages

Y. Gao, K. Nie, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, B. Huang, Y. Zhang, L. Wang (Guangzhou, China)

1:15pm-2:45pm: Characteristics of brain mri in patient with Parkinson’s disease

K. Merryn, A. Shahab, R. Faisal, S. Marisdina, E. Bahar (Palembang, Indonesia)

1:15pm-2:45pm: Cholinergic basal forebrain and hippocampal structure influence visuospatial function in Parkinson’s disease

R. Berlot, S. Brezovar, B. Koritnik, Z. Pirtošek, N. Ray (Ljubljana, Slovenia)

1:15pm-2:45pm: Classifying carriers of the G2019S mutation in the LRRK2 gene using MRI radiomics analysis

M. Artzi, A. Thaler, A. Orr Urterger, T. Hendler, M. Sela, A. Mirelman, D. Ben Bashat (Tel Aviv, Israel)

1:15pm-2:45pm: Clinical and functional network features of visuoperceptual disturbances in Parkinson’s disease

K. Kawabata, H. Watanabe, R. Ohdake, K. Hara, E. Bagarinao, T. Kato, A. Ogura, M. Masuda, T. Yokoi, T. Tsuboi, M. Katsuno, G. Sobue (Nagoya, Japan)

1:15pm-2:45pm: Clinical and imaging progression in the PARS cohort: Results from 6 years of observation

D. Jennings, A. Siderowf, S. Eberly, D. Oakes, M. Stern, K. Marek (New Haven, CT, USA)

1:15pm-2:45pm: Closed loop spinal cord stimulation restores locomotion and desynchronizes corticostriatal beta oscillations

A. Yadav, E. Borda, M. Nicolelis (Durham, NC, USA)

1:15pm-2:45pm: Cognitive networks in Parkinson’s Disease Mild Cognitive Impairment: Salience Network disruption without gray matter loss

I. Aracil, F. Sampedro, J. Marin, J. Perez, H. Bejr-Kasem, S. Martinez-Horta, A. Horta, M. Boti, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

1:15pm-2:45pm: Combined Neurite Orientation Dispersion and Density Imaging and Myelin Imaging Provide New Insights to White Matter Changes of the Neurocognitive-psychiatric Disorder in Parkinson’s Disease

C. Andica, K. Kamagata, T. Hatano, A. Saito, Y. Takenaka, T. Ogawa, G. Oyama, Y. Shimo, M. Hori, N. Hattori, S. Aoki (Tokyo, Japan)

1:15pm-2:45pm: Combining PET imaging and blood metabolomics data to improve machine learning models for Parkinson’s disease diagnosis

E. Glaab, A. Greuel, J.P. Trezzi, C. Jäger, Z. Hodak, L. Timmermann, M. Tittgemeyer, N. Diederich (Esch-sur-Alzette, Luxembourg)

1:15pm-2:45pm: Comparisons of cerebral glucose metabolism and striatal DAT binding in PD patients with and without RBD

P. Wu, Q. Xu, J. Wang, C. Zuo (Shanghai, China)

1:15pm-2:45pm: Compensatory functional activations in early-stage Parkinson’s disease: a cross-sectional motor planning fMRI study

A. Martin-Bastida, N. Lao-Kaim, S. Pietracupa, A. Roussakis, Y. Xing, S. Schwarz, D. Auer, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Complementary value of MRI-based differential diagnosis in parkinsonism

S. Kim, E. Oh, Y. Lim, J. Ham, J. Lee, E. Sohn, A. Lee (Daejeon, Republic of Korea)

1:15pm-2:45pm: Contribution of individual motor signs to striatal dopamine deficiency in parkinsonism

E. Mäkinen, J. Joutsa, E. Jaakkola, T. Noponen, J. Johansson, M. Pitkonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

1:15pm-2:45pm: DAT-imaging and clinical phenotypes of Parkinson’s disease

S. Varanese, S. Ruggieri, N. Modugno (Pozzilli, Italy)

1:15pm-2:45pm: Decreased interhemispheric homotopic connectivity in Parkinson’s disease patients with freezing of gait: A resting state fMRI study

L. Li, Y. Yuan, K. Zhang (Nanjing, China)

1:15pm-2:45pm: Derivation and characterization of Parkinson’s disease related pattern using functional magnetic resonance imaging

W. Sako, T. Abe, S. Haji, N. Murakami, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)

1:15pm-2:45pm: Diabetes Mellitus Alters Resting State Functional Networks in Early-Stage Parkinson’s Disease without Dementia

R. Ye, T. Shen, L. Xu, X. Guan, M. Zhang, B. Zhang (Hangzhou, China)

1:15pm-2:45pm: Diffusion tensor imaging of olfactory tract in Parkinson’s disease

P. Nigro, N. Tambasco, A. Chiappiniello, S. Simoni, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

1:15pm-2:45pm: Diminished fMRI global signal differences between eyes closed and eyes open resting state in RBD and PD

J. Suescun, M. Schiess, L. Giancardo, R. Castriotta, T. Ellmore (Houston, TX, USA)

1:15pm-2:45pm: Discriminating Idiopathic PD Patients and Controls in PPMI Using Integrative Multi-Modal Neuroimaging Analysis with Graph Convolutions

F. Wang, X. Zhang, L. He, C. Henchcliffe (New York, NY, USA)

1:15pm-2:45pm: Distinguishing ON from OFF Motor State by Phone Attribute Codes in Patients with Parkinson’s Disease

K. Abedinpour, A. Asaei, M. Cernak, D. Milana, T. Advani, F. Pfister, U. Fietzek (Munich, Germany)

1:15pm-2:45pm: Does dopaminergic denervation of specific anatomical regions of the basal ganglia correlate with clinical features of Parkinsonism: A quantitative DaTscan study

M. Salgado, S. Aggarwal, J. Muller, S. Singh, D. Ney (Brooklyn, NY, USA)

1:15pm-2:45pm: Does the Basal Ganglia Dysfunction Affect Pisa Syndrome in Parkinson’s Disease?

Y.E. Huh, W-H. Chung, J. Youn, J.H. Ahn, J.W. Cho (Seongnam, Republic of Korea)

1:15pm-2:45pm: Dopaminergic and Metabolic Imaging in Parkinson’s Disease motor subtypes and their relations to parkinsonian tremor

J. Zhao, L. Li, P. Wu, J. Wang, C.T. Zuo (Shanghai, China)

1:15pm-2:45pm: Early cortical signature of development of visual hallucinations in ‘de novo’ Parkinson’s disease

H. Bejr-kasem, J. Pagonabarraga, S. Martínez-Horta, F. Sampedro, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

1:15pm-2:45pm: EEG microstates changes in response to increase in dopaminergic stimulation in treated typical Parkinson’s disease patients without clinical fluctuations

V. Cortés, I. Serrano, N. Mendes, M. Del Castillo, A. Arroyo, J. Andreo, M. Del Valle, J. Herreros, JP. Romero, (Madrid, Spain)

1:15pm-2:45pm: Effect of levodopa on fronto-parietal network connectivity in freezing of gait in Parkinson’s disease

B. Bluett, E. Bayram, S. Banks, X. Zhuang, V. Mishra, Z. Yang, C. Bird, D. Cordes, Z. Mari, I. Litvan, K. Sreenivasan (Las Vegas, NV, USA)

1:15pm-2:45pm: Effects of age, motor severity and disease duration on finger tapping movement under dual-task in Parkinson’s disease patients

A. Miyake, T. Yamamoto, H. Kawasaki, N. Tamura, N. Araki (Saitama prefecture, Japan)

1:15pm-2:45pm: Effects of N-methyl-D-aspartate receptor antagonist in Parkinson’s disease with dementia

Y. Chung, I. Song, L. Lee (Incheon, Republic of Korea)

1:15pm-2:45pm: Effects of subthalamic nucleus deep brain stimulation in Parkinson’s disease are mediated by a prefronto-cerebellar-striatal loop

H. Hanssen, J. Steinhardt, A. Al-Zubaidi, A. Muenchau, M. Heldmann, P. Schramm, A. Neumann, D. Rasche, A. Saryyeva, J. Voges, I. Galazky, L. Buentjen, H. Heine, J. Krauss, V. Tronnier, T. Muente, N. Brueggemann (Luebeck, Germany)

1:15pm-2:45pm: Evaluation of bradykinesia in Parkinson’s disease using a computerised evolutionary algorithm

R. Newby, S. Muhamed, P. Kempster, J. Alty, S. Jamieson, J. Cosgrove, S. Smith (Leeds, United Kingdom)

1:15pm-2:45pm: Executive Function and Frontoparietal Network Association in Freezing of Gait

E. Bayram, K. Sreenivasan, S. Banks, X. Zhuang, V. Mishra, D. Cordes, B. Bluett (Las Vegas, NV, USA)

1:15pm-2:45pm: Exploring novel diffusion-derived biomarkers in Parkinson’s disease Freezing of Gait

B. Bluett, E. Bayram, S. Banks, Z. Mari, K. Sreenivasan, X. Zhuang, Z. Yang, C. Bird, D. Cordes, I. Litvan, V. Mishra (Las Vegas, NV, USA)

1:15pm-2:45pm: Feasibility aspects of evaluating neuroplastic changes after balance training in Parkinson´s disease: A pilot randomised controlled trial

H. Johansson, M. Hagströmer, U. Ekman, B. Leavy, M. Freidle, E. Schalling, P. Svenningsson, E. Franzén (Huddinge, Sweden)

1:15pm-2:45pm: Functional connectivity changes in relation to dopaminergic decline in Parkinson’s over time: A resting-state fMRI and 11C-PE2I PET imaging study

W. Li, N. Lao-Kaim, A. Roussakis, A. Martín-Bastida, N. Valle-Guzman, G. Paul, E. Soreq, R. Daws, T. Foltynie, R. Barker, A. Hampshire, P. Piccini (London, United Kingdom)

1:15pm-2:45pm: Further insights into excitatory-inhibitory balance of the primary motor cortex in Parkinson’s disease: A triple-pulse stimulation study

Y. Shirota, Y. Terao, Y. Ugawa, R. Hanajima (Tokyo, Japan)

1:15pm-2:45pm: Gender Differences in Parkinson’s disease: Transcranial Magnetics Stimulation Study of Newly Diagnosed Drug-Naïve PD Patients

K. Kolmancic, R. Alfonso, Z. Pirtosek, K. Bhatia, M. Kojovic (Ljubljana, Slovenia)

1:15pm-2:45pm: Gender-specific pattern of sensori-motor network connectivity in early untreated Parkinson’s disease patients

R. De Micco, F. Esposito, F. Di Nardo, A. De Mase, G. Caiazzo, A. Giordano, M. Siciliano, G. Tedeschi, A. Tessitore (Naples, Italy)

1:15pm-2:45pm: Higher motor cortex connectivity with subthalamic stimulation than with levodopa: A resting state fMRI study in Parkinson’s disease

R. Jech, K. Mueller, F. Růžička, Š. Holiga, T. Ballarini, O. Bezdicek, H. Möller, J. Vymazal, E. Růžička, L. Schroeter, D. Urgošík (Prague, Czech Republic)

1:15pm-2:45pm: Hypometabolism of the posterior parietal cortex in Parkinson’s disease with mild cognitive impairment predicts the conversion to dementia: 5-year longitudinal observations

KW. Park, NR. Choi, JH. Ko, SJ. Kim, SJ. Chung, CS. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Hypometabolism of the posterior parietal cortex in PD with dementia: [18F]FDG PET study

N.R. Choi, K.W. Park, M.S. Kim, J.H. Ko, S.J. Kim, S.J. Chung, C.S. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Identifying the neural correlates of doorway freezing in Parkinson’s disease

E. Matar, J. Shine, P. Ward, M. Gilat, K. Ehgoetz-Martens, M. Frank, A. Moustafa, S. Naismith, S. Lewis (Sydney, Australia)

1:15pm-2:45pm: Impaired stopping reversed through dopamine replacement in Parkinson’s disease

S. Choudhury, A. Roy, R. Singh, K. Chatterjee, B. Mondal, M. Baker, S. Baker, H. (Kolkata, India)

1:15pm-2:45pm: Impaired topographic organization in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson’s disease

Y.B. Hou, Q.Q. Wei, R.W. Ou, J. Yang, W. Song, Q.Y. Gong, H.F. Shang (Chengdu, People’s Republic of China)

1:15pm-2:45pm: Improvement of antisaccade amplitude by the STN DBS and target eccentricity

A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

1:15pm-2:45pm: In vivo MRI signatures of hippocampal subfield pathology in patients with Parkinson’s disease and psychosis

A. Lenka, M. Ingalhalikar, A. Shah, J. Saini, S. Hegde, A. Shyam Sundar, R. Yadav, P. Pal (Bangalore, India)

1:15pm-2:45pm: In vivo staging of pathology in REM sleep behaviour disorder

K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, M. Otto, K. Svendsen, A. Nahimi, M. Stokholm, N. Pavese, C. Beier, D. Brooks, P. Borghammer (Aarhus, Denmark)

1:15pm-2:45pm: Intrinsic functional connectivity correlates of anxiety in cognitively unimpaired drug-naïve patients with Parkinson’s disease

R. De Micco, M. Siciliano, F. Di Nardo, A. De Mase, A. Giordano, G. Caiazzo, F. Esposito, G. Tedeschi, A. Tessitore (Naples, Italy)

1:15pm-2:45pm: L-Dopa Responsiveness is Correlated to Fluorodeoxyglucose Metabolism and Dopamine Transporter Availability in Parkinson’s Disease

D. Su, W. Hu, X. Zhao, Z. Liu, H. Ma, J. Zhou, T. Feng (Beijing, China)

1:15pm-2:45pm: Long-term and dopamine dependent dynamics of subthalamic nucleus local field potentials in Parkinson’s disease

N. Drummond, K. Udupa, U. Saha, T. Hoque, J. Saravanamuttu, A. Fasano, A. Lozano, M. Hodaie, S. Kalia, R. Chen (Toronto, ON, Canada)

1:15pm-2:45pm: Longitudinal changes in Neuromelanin MRI Signal in Parkinson’s Disease

R. Gaurav, N. Pyatigorskaya, C. Ewenczyk, R. Valabregue, K. Evans, I. Arnulf, M. Vidailhet, S. Lehéricy (Paris, France)

1:15pm-2:45pm: Longitudinal decline in white matter integrity in Parkinson’s disease: An analysis of Parkinson Progression Markers Initiative diffusion tensor imaging data

K. Taylor, F. Sambataro, A. Bertolino, J. Dukart (Basel, Switzerland)

1:15pm-2:45pm: Longitudinal development of nigral iron load in Parkinson’s Disease

S. Franthal, L. Pirpamer, C. Rodler, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, R. Schmidt, P. Schwingenschuh (Graz, Austria)

1:15pm-2:45pm: Longitudinal MRI to predict cognitive impairment in Parkinson’s disease

T. Melzer, D. Myall, L. Livingston, M. Almuqbel, M. MacAskill, T. Pitcher, K. Horne, S. Grenfell, M. Pascoe, D. Miller, R. Keenan, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

1:15pm-2:45pm: Microstructural Abnormalities in Drug-naïve Parkinson’s Disease with Mild Cognitive Impairment: A Diffusion Tensor Imaging Study

N. Li, L. Wang, X. Suo, Z. Lu, J. Li, J. Peng, Q. Gong, R. Peng (Chengdu, Sichuan Province, China)

1:15pm-2:45pm: Microstructural Changes in Normal Appearing White Matter in Parkinson’s Disease (PD) Correlate with Motor, Tremor, and Neuropsychiatric Scores

J. Kim, T. Baumeister, M. McKeown (Vancouver, BC, Canada)

1:15pm-2:45pm: Microstructural changes in white and grey matter related to apathy, depression and anxiety in de novo Parkinson’s disease patients

S. Prange, E. Metereau, A. Maillet, E. Lhommée, H. Klinger, P. Pelissier, D. Ibarrola, RA. Heckemann, E. Broussolle, A. Castrioto, L. Tremblay, V. Sgambato, P. Krack, S. Thobois (Bron, France)

1:15pm-2:45pm: Mineralization pattern of the deep gray matter by susceptibility-weighted magnetic resonance imaging to differentiate Parkinsonian disorders

M. Modi, P. Singh (Chandigarh, India)

1:15pm-2:45pm: Motor cortical inhibitory and facilitatory circuit interactions in Parkinson’s disease

J. Saravanamuttu, N. Radhu, K. Udupa, C. Gunraj, J. Baarbé, R. Chen (Toronto, ON, Canada)

1:15pm-2:45pm: Multi-echo GRE and DTI MR imaging of the Substantia Nigra in early Parkinson’s disease: A pilot 1-year prospective controlled study

T. Mestre, G. Melkus, G. Santos, D. Grimes, S. Chakraborty (Ottawa, ON, Canada)

1:15pm-2:45pm: Neuroinflammation Predicts Dompaminergic Deficit in Early Parkinson Disease: DAT SPECT Imaging Study

F. Rahmani, M. Rahmani (Tehran, Islamic Republic of Iran)

1:15pm-2:45pm: Neuromodulation by rTMS in Parkinsons Disease: A fMRI Study

P. Bhat, V. Goyal, S. Kumaran, C. Goyal, A. Srivastava, M. Behari, S. Dwivedi (New Delhi, India)

1:15pm-2:45pm: New approach to assess changes in brain activation during real walking using EEG

I. Maidan, S. Shustak, T. Shiner, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

1:15pm-2:45pm: Non-invasive, automated corneal nerve quantification reveals neurodegeneration in Parkinson’s disease: A potential novel imaging biomarker

S. Lim, M. Ferdousi, A. Kalteniece, C. Kobylecki, R. Malik, M. Silverdale (Salford, United Kingdom)

1:15pm-2:45pm: Olfactory dysfunction, sleep disturbances, neuronal loss, and regional brain atrophy in an inducible mouse model of Alpha-Synucleinopathy

E. Brison, S. Zehntner, A. Zijdenbos, K. Luk, B. Bedell (Montreal, QC, Canada)

1:15pm-2:45pm: Optimization of deep brain stimulation in STN among patients with Parkinson’s disease using a novel EEG-based tool

D. Sand, Z. Peremen, D. Haor, S. Israeli-Korn, D. Arkadir, M. Abu Snineh, Z. Israel, S. Hassin-Baer, R. Eitan, H. Bergman, A. Geva (Jerusalem and Herzlia, Israel)

1:15pm-2:45pm: Pallidal beta bursts in Parkinson’s disease and Dystonia

R. Lofredi, WJ. Neumann, C. Brücke, J. Huebl, GH. Schneider, A. Kühn (Berlin, Germany)

1:15pm-2:45pm: Paraneoplastic and neuronal surface antibodies in Parkinson’s disease and atypical parkinsonian disorders

R. Constantinescu, C. Malmeström, D. Krýsl, D. Jons, M. Axelsson (Gothenburg, Sweden)

1:15pm-2:45pm: Parkinson’s disease motor symptoms are linked to red nucleus volume and cerebellar metabolism

A. Bonnet, R. Sanford, A. Riou, S. Drapier, F. Le Jeune, M. Vérin, D.L. Collins (Rennes, France)

1:15pm-2:45pm: Patterns of rhythmic single unit activity of the subthalamic nucleus in patients with Parkinson’s disease

E. Belova, A. Nezvinskiy, R. Medvednik, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

1:15pm-2:45pm: Pisa syndrome in Parkinson’s disease: Evidence for bilateral vestibulospinal dysfunction

G. Di Lazzaro, T. Schirinzi, S. Di Girolamo, R. Di Mauro, A. Pisani (Rome, Italy)

1:15pm-2:45pm: Potential indicator of antiparkinsonian drug efficacy: an attempt to explore imaging findings

S. Taguchi, N. Tanabe, H. Oiwa, M. Hayashi, C. Nagatomi, S. Saeki, K. Nakashima, T. Yuasa, A. Yasumoto, H. Ando, T. Higa, A. Fujikake, T. Fukuoka, K. TokuI, Y. Okada, J. Niwa, M. Izumi, N. Nakao, M. Doyu (Nagakute, Japan)

1:15pm-2:45pm: Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson’s disease

HS. Yoo, SJ. Chung, BS. Ye, YH. Sohn, PH. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Prevalence of Autonomic dysfunction and its correlation with Clinico-imageological features in Parkinson’s Disease

R. Borgohain, S. Turaga, R. Kandadai, S. Tandra, M. Katragadda, S. Meka, T. Syed (Hyderabad, India)

1:15pm-2:45pm: Putaminal dopamine depletion in de novo Parkinson’s disease predicts future development of wearing-off

S.J. Chung, Y. Lee, J.S. Oh, J.S. Kim, P.H. Lee, Y.H. Sohn (Goyang, Republic of Korea)

1:15pm-2:45pm: Quantification of the PD Motor Syndrome Using an Inclusive Score (PD9) Derived from Sensor Data with Deep Learning

F. Pfister, J. Goschenhofer, T. Um, D. Pichler, K. Abedinpour, D. Kulic, B. Bischl, A. Ceballos-Baumann, U. Fietzek (Munich, Germany)

1:15pm-2:45pm: Quantitative analysis of DaT uptake and neuromelanin MR contrast in patients with Parkinson’s disease and healthy controls

D. Ben Bashat, M. Artzi, A. Mirelman, T. Thaler, A. Orr Urterger, M. Weisz, E. Even-Sapir, K. Evans, R. Hutchison, J. Cedarbaum, H. Lerman Shacham (Tel Aviv, Israel)

1:15pm-2:45pm: Relation of asymmetry of dopamine depletion with motor or non-motor symptoms in patients with Parkinson’s disease: A pilot study

K.Y. Kwon, J.Y. Lee, K. Im (Seoul, Republic of Korea)

1:15pm-2:45pm: Relationships between specific subtypes of mild cognitive impairment and grey matter atrophy in Parkinson’s disease

K. Nie, M. Mei, Y. Gao, M. Guo, B. Huang, Z. Huang, L. Wang, J. Zhao, Y. Zhang, D. Xiong, L. Wang (Guangzhou, China)

1:15pm-2:45pm: Remote patient monitoring with a digital biomarker approach generates clinically distinctive and meaningful sensor feature data in Parkinson’s disease: Differential relationships with MDS-UPDRS-III, PDQ-39 and DaT-SPECT

F. Lipsmeier, K. Taylor, R. Postuma, D. Wolf, T. Kilchenmann, A. Scotland, J. Schjodt-Erkisen, W. Cheng, J. Siebourg-Polster, L. Jin, J. Soto, L. Verselis, F. Boess, M. Koller, M. Grundman, T. Kremer, C. Czech, C. Gossens, M. Lindemann (Basel, Switzerland)

1:15pm-2:45pm: Research on nearinfrared brain function imaging for Freezing of Gait in Parkinson’s Disease

Y. Jingjing, L. Zhanhua, C. Ming (Dalian, China)

1:15pm-2:45pm: Resting state fMRI points to disparate brain network activations in early Parkinson’s disease

L. Salamanca, E. Glaab, R. Balling, G. Dooms, N. Diederich (Esch-sur-Alzette, Luxembourg)

1:15pm-2:45pm: Resting-state connectivity and cognitive changes in Parkinson’s disease: A four-year follow-up study

HC. Baggio, B. Segura, A. Abos, A. Campabadal, C. Uribe, A.I. Garcia-Diaz, M.J. Marti, Y. Compta, F. Valldeoriola, C. Junque (Barcelona, Spain)

1:15pm-2:45pm: Return to automaticity: cortical activity during gait in Parkinson’s disease

S. Stuart, R. Morris, G. Booth, M. Mancini (Portland, OR, USA)

1:15pm-2:45pm: Semi-automated segmentation and quantification of the substantia nigra depigmentation in Parkinson’s disease – a multicentre case control MRI study in 284 participants

Y. Xing, S. Schwarz, A. Martin-Bastida, L. Parkes, H. Abdul-Sapuan, S. Naidu, M. Silverdale, D. Grosset, P. Piccini, D. Burn, N. Bajaj, N. Pavese, D. Auer (Nottingham, United Kingdom)

1:15pm-2:45pm: STN DBS modulates cortical auditory processing in advanced Parkinson’s Disease; a MEG-study

K. Valkonen, J. Mäkelä, K. Airaksinen, J. Nurminen, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

1:15pm-2:45pm: Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson’s disease

YS. Oh, DW. Ryu, JS. Kim, CH. Lyoo (Seoul, Republic of Korea)

1:15pm-2:45pm: Structural Abnormalities in the Cerebellar Peduncles of patients with Freezing of Gait: A Diffusion Tensor Imaging Study

K. Bharti, A. Suppa, S. Pietracupa, N. Upadhyay, C. Giannì, G. Leodori, F. Di Biaso, N. Modugno, N. Petasas, G. Grilla, A. Zampogna, A. Berardelli, P. Pantano (Rome, Italy)

1:15pm-2:45pm: Structural neural correlates of independent gait domains in Parkinson’s disease

J. Wilson, B. Galna, S. Lord, A. Yarnall, R. Lawson, G. Duncan, T. Khoo, D. Burn, L. Rochester, J.P. Taylor (Newcastle upon Tyne, United Kingdom)

1:15pm-2:45pm: Study on feasibility to develop a central nervous system (CNS) Leucine-rich repeat kinase 2 (LRRK2) PET tracer

Z. Zeng, P. Miller, T. Graham, L. Tong, D. Hesk, W. Li, E. Hostetler (West Point, PA, USA)

1:15pm-2:45pm: Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson’s Disease

P. Huang, H.Y. Zhou, S.D. Chen (Shanghai, China)

1:15pm-2:45pm: Substantia nigra T1 maps for the diagnosis of Parkinson’s disease

C. Juri, L. Tapia, J. Cruz, S. Uribe, M. Andia (Santiago, Chile)

1:15pm-2:45pm: Subthalamic Nucleus Local Field Potential Beta Activity in Chinese Advanced PD Patients

J. Wu, J. Li, C. Xu, S. Mei, Y. Zhang (Minneapolis, MN, USA)

1:15pm-2:45pm: Subthalamic theta oscillations in Parkinson’s disease

C. Oehrn, I. Weber, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)

1:15pm-2:45pm: The difference in cerebellar blood flow reduction in multiple system atrophy and Parkinson’s disease

N. Murakami, W. Sako, S. Haji, Y. Izumi, R. Kaji (Tokushima, Japan)

1:15pm-2:45pm: The effect of age on Substantia Nigra Hyperechogenicity in PD patients and healthy controls

T. Toomsoo, A-H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, I. Rubanovits, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)

1:15pm-2:45pm: The neural effects of a randomized controlled cognitive training program for treating freezing of gait in Parkinson’s disease

M. Gilat, C. Walton, L. Mowszowski, J. Shine, J. Hall, M. Georgiades, A. Muller, C. O'Callaghan, K. Ehgoetz Martens, J. Szeto, S. Naismith, S. Lewis (Sydney, Australia)

1:15pm-2:45pm: The role of exposure to pesticides in the etiology of Parkinson’s disease: F-DOPA positron emission tomography study

R. Djaldetti, A. Steinmetz, A. Rigbi, Y. Roditi, L. Greenbaum, M. Lorberboym (Petah Tiqva, Israel)

1:15pm-2:45pm: The study of 18F-FDG PET / CT imaging in the value on Parkinson’s disease

Z. Mao, Z. Xue (Hubei, China)

1:15pm-2:45pm: The use of DaT scan for diagnosis of Idiopathic Parkinson’s disease and Parkinson’s Plus syndromes in clinical practice (HEFT experience)

M. Awadh, G. Ferris, K. Alam (Birmingham, United Kingdom)

1:15pm-2:45pm: The use of DaT-SPECT scanning in the differential diagnosis of Parkinsonism: Are guidelines being followed?

J. Carling, A. Coldstream, W. Gray, R. Walker (Newcastle upon Tyne, United Kingdom)

1:15pm-2:45pm: The usefulness of 18 F-DOPA PET scan in diagnostically challenging patients at a movement disorder clinic

M. Khider, A. Dorutyer, J. Warwick, J. Carr (Cape Town, South Africa)

1:15pm-2:45pm: Three Tesla susceptibility-weighted MR imaging of parkinsonism and idiopathic REM sleep behavior disorder: Comparison with 123I-FP-CIT SPECT

J.M. Kim, Y.J. Bae, Y.S. Song, K.J. Kim, S.E. Kim, B. Jeon (Seongnam-si, Republic of Korea)

1:15pm-2:45pm: Tractographically defined subthalamic connectivity is associated with apathy in Parkinson’s disease and healthy subjects

N. Vanegas-Arroyave, Y. Gazes, D. Tomishon, A. Boehme (New York, NY, USA)

1:15pm-2:45pm: Transcranial imaging of substantia nigra hyperechogenicity in a Chinese cohort of Parkinson’s disease

G. Hongling, Y. Qingmei (Wuhan, China)

1:15pm-2:45pm: Ultrasonographic signatures associated with movement disorders (USA-MD study): A population-based longitudinal study

A. Crespo Cuevas, L. Ispierto, E. Lopez-Cancio, A. Planas, T. Canento, M. Hernandez-Pérez, R. Alvarez, D. Vilas (Badalona, Spain)

1:15pm-2:45pm: Unilateral abnormal dopamine transporter (DaT) scans: Early indicator of Parkinson’s disease and degenerative Parkinsonism

N. Heng, M.Y. Chin, C. Monaghan, J. Dadvidson, T. Gilbertson, M. Muqit (Dundee, United Kingdom)

1:15pm-2:45pm: What happens when I watch a ballet? Preliminary fMRI findings on somatosensory empathy in Parkinson Disease

S. Palermo, R. Morese, M. Zibetti, M. Stanziano, A. Pontremoli, A. Romagnolo, G. Carlotti, A. Zardi, M. Valentini, L. Lopiano (Turin, Italy)

1:15pm-2:45pm: White Matter Hyperintensities and Mortality among Patients with Parkinsonism in Olmsted County, MN (1995-2010)

J. Yu, R. Brown, J. Huston, M. Mielke, C. stang, P. Turcano, R. Savica (Rochester, MN, USA)

1:15pm-2:45pm: α4β2-nicotinic receptor availability in Parkinson’s disease MCI and healthy controls: A pilot imaging study using [18F]-XTRA PET

K. Mills, Y. Du, J. Coughlin, A. Horti, M. Pomper, G. Smith (Baltimore, MD, USA)

« View all sessions from the 2018 International Congress.